Heart Failure: Treatment strategies for heart failure: beta blockers andantiarrhythmics.
作者信息
Maggioni A P
机构信息
Director of the Research Center of the Italian Association of Hospital Cardiologists (ANMCO), Firenze, Italy.
出版信息
Heart. 2001 Jan;85(1):97-103. doi: 10.1136/heart.85.1.97.
Abstract
摘要
相似文献
1
Heart Failure: Treatment strategies for heart failure: beta blockers andantiarrhythmics.
Heart. 2001 Jan;85(1):97-103. doi: 10.1136/heart.85.1.97.
2
Beta blockers as anti-arrhythmic agents.β受体阻滞剂作为抗心律失常药物。
Heart Fail Rev. 2004 Apr;9(2):139-47. doi: 10.1023/B:HREV.0000046369.90417.db.
3
[Antiarrhythmic drug therapy in patients with heart failure].[心力衰竭患者的抗心律失常药物治疗]
Nihon Rinsho. 2007 May 28;65 Suppl 5:369-74.
4
Beta blocker treatment in heart failure.心力衰竭中的β受体阻滞剂治疗
Prog Cardiovasc Dis. 1999 Jan-Feb;41(4):301-21. doi: 10.1053/pcad.1999.0410301.
5
Carvedilol for heart failure: more than just a beta-blocker?卡维地洛用于治疗心力衰竭：它仅仅是一种β受体阻滞剂吗？
Br J Hosp Med. 1997;58(10):493-7.
6
[Drug therapy of chronic heart failure: when are beta receptor blockers indicated?].[慢性心力衰竭的药物治疗：β受体阻滞剂何时适用？]
Dtsch Med Wochenschr. 1999 Sep 24;124 Suppl 2:S48-53.
7
Heart failure trials.心力衰竭试验
Br J Hosp Med. 1996;56(1):29-31.
8
9
Heart rate decrease: a new paradigm in the treatment of heart failure. Insights from the SHIFT study.心率降低：心力衰竭治疗的新范式。SHIFT研究的见解。
Arch Cardiovasc Dis. 2011 Feb;104(2):67-9. doi: 10.1016/j.acvd.2011.01.001. Epub 2011 Feb 17.
10
[Treatment of heart failure with beta-receptor-blockers].
Dtsch Med Wochenschr. 2002 Mar 29;127(13):682-8. doi: 10.1055/s-2002-23483.
本文引用的文献
1
Implantable cardioverter defibrillator therapy: the sickest patients benefit the most.
Circulation. 2000 Apr 11;101(14):1638-40. doi: 10.1161/01.cir.101.14.1638.
2
beta-adrenergic receptor blockade in chronic heart failure.慢性心力衰竭中的β-肾上腺素能受体阻滞剂
Circulation. 2000 Feb 8;101(5):558-69. doi: 10.1161/01.cir.101.5.558.
3
Introducing new treatments in clinical practice: the Italian approach to beta blockers in heart failure.临床实践中引入新疗法：意大利使用β受体阻滞剂治疗心力衰竭的方法。
Heart. 1999 May;81(5):453-4. doi: 10.1136/hrt.81.5.453.
4
Clinical effects of beta-adrenergic blockade in chronic heart failure: a meta-analysis of double-blind, placebo-controlled, randomized trials.β-肾上腺素能阻滞剂在慢性心力衰竭中的临床疗效：双盲、安慰剂对照、随机试验的荟萃分析
Circulation. 1998 Sep 22;98(12):1184-91. doi: 10.1161/01.cir.98.12.1184.
5
The role of beta-blockers in left ventricular dysfunction and heart failure.β受体阻滞剂在左心室功能不全和心力衰竭中的作用。
Drugs. 1997 Oct;54(4):501-10. doi: 10.2165/00003495-199754040-00001.
6
Medical therapy can improve the biological properties of the chronically failing heart. A new era in the treatment of heart failure.药物治疗可以改善长期衰竭心脏的生物学特性。心力衰竭治疗的新时代。
Circulation. 1996 Nov 1;94(9):2285-96. doi: 10.1161/01.cir.94.9.2285.
7
The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group.卡维地洛对慢性心力衰竭患者发病率和死亡率的影响。美国卡维地洛心力衰竭研究组。
N Engl J Med. 1996 May 23;334(21):1349-55. doi: 10.1056/NEJM199605233342101.
8
Randomised trial of low-dose amiodarone in severe congestive heart failure. Grupo de Estudio de la Sobrevida en la Insuficiencia Cardiaca en Argentina (GESICA).低剂量胺碘酮治疗重度充血性心力衰竭的随机试验。阿根廷心脏衰竭生存研究小组（GESICA）。
Lancet. 1994 Aug 20;344(8921):493-8. doi: 10.1016/s0140-6736(94)91895-3.
9
Time course of improvement in left ventricular function, mass and geometry in patients with congestive heart failure treated with beta-adrenergic blockade.β-肾上腺素能阻滞剂治疗的充血性心力衰竭患者左心室功能、质量和几何形状改善的时间进程。
J Am Coll Cardiol. 1995 Apr;25(5):1154-61. doi: 10.1016/0735-1097(94)00543-y.
10
Adverse consequences of high sympathetic nervous activity in the failing human heart.衰竭的人类心脏中高交感神经活性的不良后果。
J Am Coll Cardiol. 1995 Nov 1;26(5):1257-63. doi: 10.1016/0735-1097(95)00332-0.
Zotero 插件